Tex. Occ. Code Section 562.052
Release of Confidential Records

A confidential record is privileged and a pharmacist may release a confidential record only to:

(1)

the patient or the patient’s agent;

(2)

a practitioner or another pharmacist if, in the pharmacist’s professional judgment, the release is necessary to protect the patient’s health and well-being;

(3)

the board or to a person or another state or federal agency authorized by law to receive the confidential record;

(4)

a law enforcement agency engaged in investigation of a suspected violation of Chapter 481 (Texas Controlled Substances Act) or 483 (Dangerous Drugs), Health and Safety Code, or the Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 U.S.C. Section 801 et seq.);

(5)

a person employed by a state agency that licenses a practitioner, if the person is performing the person’s official duties; or

(6)

an insurance carrier or other third party payor authorized by the patient to receive the information.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.

Source: Section 562.052 — Release of Confidential Records, https://statutes.­capitol.­texas.­gov/Docs/OC/htm/OC.­562.­htm#562.­052 (accessed Jun. 5, 2024).

562.001
Definitions 562.002
Legislative Intent 562.003
Disclosure of Price 562.004
Prescription Transmitted Orally by Practitioner 562.005
Record of Dispensed Drug or Biological Product 562.006
Label 562.007
Refills 562.008
Generic Equivalent or Interchangeable Biological Product Authorized 562.009
Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product 562.010
Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product 562.011
Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product 562.012
Substitution of Dosage Form Permitted 562.013
Applicability of Subchapter 562.014
Narrow Therapeutic Index Drugs 562.015
Dispensing Directive 562.016
List of Approved Interchangeable Biological Products 562.0051
Communication Regarding Certain Dispensed Biological Products 562.052
Release of Confidential Records 562.053
Reports to Board 562.054
Emergency Refills 562.055
Report to Texas Department of Health 562.056
Practitioner-patient Relationship Required 562.057
Administration of Epinephrine 562.0061
Other Prescription Information 562.0062
Required Statement Regarding Medication Disposal 562.101
Supervision of Pharmacy 562.102
Confidential Record 562.103
Display of Licenses by Pharmacy 562.104
Toll-free Telephone Number Required 562.105
Maintenance of Records 562.106
Notification 562.107
Written Consumer Information Required 562.108
Emergency Medication Kits 562.109
Automated Pharmacy Systems 562.110
Telepharmacy Systems 562.112
Practitioner-patient Relationship Required 562.0141
Transplant Immunosuppressant Drug Product Selection Prohibited 562.0142
Adoption of Rules 562.151
Definitions 562.152
Compounding for Office Use 562.153
Requirements for Office Use Compounding 562.154
Distribution of Compounded and Prepackaged Products to Certain Pharmacies 562.155
Compounding Service and Compounded Drug Products 562.156
Compounded Sterile Preparation 562.0541
Emergency Refills of Insulin and Insulin-related Equipment or Supplies 562.1011
Operation of Class C Pharmacy in Certain Rural Hospitals 562.1045
Linking Internet Sites 562.1085
Unused Drugs Returned by Certain Pharmacists 562.1086
Limitation on Liability
Green check means up to date. Up to date

Accessed:
Jun. 5, 2024

§ 562.052’s source at texas​.gov